A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

To analyze human tumors for the presence of mutated ras oncogenes, a procedure was developed based on selective hybridization of mutation-specific oligodeoxynucleotide probes to genomic DNA [Bos et al., Nucl. Acids Res. 12 (1984) 9155-9163]. We have improved this procedure both in sensitivity and speed by including an in vitro amplification step of ras-specific sequences. This amplification step has first been described by Saiki et al. [Science 230 (1985) 1350-1353] and results in a more than 10(4)-fold increase in the sequence which might contain the mutation. Furthermore, we have improved the selectivity of our hybridizations. As a result, mutated ras oncogenes can now be detected with a dot-blot screening procedure requiring less than 1 microgram of tumor DNA.

[1]  R. Bast,et al.  Somatic activation of rasK gene in a human ovarian carcinoma. , 1984, Science.

[2]  P. Chardin,et al.  N‐ras gene activation in the rd human rhabdomyosarcoma cell line , 1985, International journal of cancer.

[3]  S. Rodenhuis,et al.  Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood , 1986 .

[4]  J. L. Bos,et al.  Mutations in N-ras predominate in acute myeloid leukemia. , 1987, Blood.

[5]  R. Weinberg,et al.  Characterization of a human colon/lung carcinoma oncogene , 1983, Nature.

[6]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[7]  S. Aaronson,et al.  Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. L. Bos,et al.  A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. , 1986, Nucleic acids research.

[9]  P. V. von Hippel,et al.  Alteration of the relative stability of dA-dT and dG-dC base pairs in DNA. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Vogelstein,et al.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. , 1985, Biochemical and biophysical research communications.

[11]  C. Marshall,et al.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia , 1985, Nature.

[12]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[13]  C. Marshall,et al.  Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Marshall,et al.  Mechanism of activation of an N‐ras gene in the human fibrosarcoma cell line HT1080. , 1984, The EMBO journal.

[15]  J. Rhim,et al.  Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours , 1984, Nature.

[16]  M. Kraus,et al.  A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Groffen,et al.  Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. , 1986, Nucleic acids research.

[18]  S. Srivastava,et al.  High frequency of N-ras activation in acute myelogenous leukemia , 1986 .

[19]  J. Bos,et al.  Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. , 1984, Nucleic acids research.

[20]  P. Seeburg,et al.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations , 1983, Nature.